CARLISI, Melania
 Distribuzione geografica
Continente #
NA - Nord America 3.565
EU - Europa 1.437
AS - Asia 1.167
Continente sconosciuto - Info sul continente non disponibili 231
SA - Sud America 221
AF - Africa 41
OC - Oceania 1
Totale 6.663
Nazione #
US - Stati Uniti d'America 3.498
SG - Singapore 486
IT - Italia 467
RU - Federazione Russa 427
CN - Cina 280
BR - Brasile 170
DE - Germania 119
HK - Hong Kong 115
VN - Vietnam 96
PL - Polonia 86
GB - Regno Unito 75
FR - Francia 69
FI - Finlandia 64
BD - Bangladesh 31
JP - Giappone 29
CA - Canada 26
IE - Irlanda 26
IN - India 24
AR - Argentina 21
IQ - Iraq 16
BE - Belgio 15
ES - Italia 13
UA - Ucraina 13
UZ - Uzbekistan 13
MX - Messico 12
SE - Svezia 12
TR - Turchia 12
KR - Corea 11
NL - Olanda 11
RO - Romania 10
ZA - Sudafrica 10
AT - Austria 9
EG - Egitto 9
CO - Colombia 7
JO - Giordania 7
VE - Venezuela 7
CL - Cile 6
CR - Costa Rica 6
HN - Honduras 6
MA - Marocco 6
PK - Pakistan 6
IR - Iran 5
JM - Giamaica 5
ID - Indonesia 4
IL - Israele 4
NP - Nepal 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
CI - Costa d'Avorio 3
DK - Danimarca 3
EC - Ecuador 3
KE - Kenya 3
LT - Lituania 3
SA - Arabia Saudita 3
TN - Tunisia 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
CH - Svizzera 2
DZ - Algeria 2
GR - Grecia 2
GT - Guatemala 2
IS - Islanda 2
KZ - Kazakistan 2
MY - Malesia 2
PR - Porto Rico 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
HR - Croazia 1
HT - Haiti 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MM - Myanmar 1
NI - Nicaragua 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.434
Città #
Ashburn 502
Fairfield 346
Singapore 304
San Jose 277
Chandler 191
Woodbridge 146
Houston 127
Wilmington 118
Cambridge 114
Palermo 111
Seattle 111
Hong Kong 107
Ann Arbor 106
Council Bluffs 93
Zgierz 75
Moscow 68
Beijing 64
Dallas 55
Los Angeles 53
New York 51
Des Moines 50
Helsinki 49
Lauterbourg 38
Medford 38
Milan 34
Chicago 33
Hanoi 33
Altamura 29
Boardman 29
Hefei 27
Santa Clara 27
Tokyo 27
Dublin 26
Rome 25
Ho Chi Minh City 24
Princeton 24
Lawrence 21
The Dalles 21
Bremen 20
São Paulo 20
London 17
Buffalo 16
Nanjing 16
San Diego 16
Denver 15
Frankfurt am Main 15
Ludwigshafen am Rhein 15
Brussels 14
Orem 14
Piscataway 14
Tashkent 13
Lappeenranta 12
Shenyang 12
Toronto 12
Munich 11
Washington 11
Brooklyn 10
Nuremberg 10
Phoenix 10
Warsaw 10
Atlanta 9
Turin 9
Columbus 8
Redondo Beach 8
Amman 7
Bari 7
Cairo 7
Dearborn 7
Salt Lake City 7
Catania 6
Mexico City 6
Ningbo 6
Poplar 6
Redwood City 6
San Francisco 6
San José 6
Santo André 6
Torino 6
Vicenza 6
Chennai 5
Da Nang 5
Düsseldorf 5
Guangzhou 5
Montreal 5
Naples 5
Portsmouth 5
Queens 5
Shanghai 5
Venice 5
Ankara 4
Belo Horizonte 4
Boston 4
Bến Tre 4
Cagliari 4
Central 4
Hebei 4
Jiaxing 4
Jinan 4
Johannesburg 4
Kingston 4
Totale 4.100
Nome #
The Essential Thrombocythemia in 2020: What We Know and Where We Still Have to Dig Deep 437
Clinical phenotype and response to different lines of therapy in elderly with immune thrombocytopenia: A retrospective study 343
Comparison between thrombotic risk scores in Essential Thrombocythemia and survival implications 315
Aspetti emoreologici nella iperviscosità policitemica e sierica 290
Extracellular vesicle microRNAs contribute to the osteogenic inhibition of mesenchymal stem cells in multiple myeloma 243
Hemorheological parameters in Monoclonal Gammopathy of Undetermined Significance (MGUS) 241
Erythrocyte deformability and hemorheological profile in multiple myeloma 240
Antimicorbial prophylaxis in patients with immune thrombocytopenia treated with rituximab:a retrospective analysis 228
Immunosenescence and lymphomagenesis 221
Late onset of unilateral optic disk edema secondary to treatment with imatinib mesylate 217
Cardio-oncology in multiple myeloma: is it time for a specific focus? 216
Monoclonal Gammopathies and the Bone Marrow Microenvironment: From Bench to Bedside and Then Back Again 213
Clinical disorders responsible for plasma hyperviscosity and skin complications 213
Evaluation of Bone Marrow CD8+ tissue-Resident Memory T Cells in Multiple Myeloma 204
EVALUATION AND POTENTIAL ROLE OF BONE MARROW TISSUE-RESIDENT MEMORY T-CELLS IN PATIENTS WITH PLASMA CELL DYSCRASIAS 191
Lymphomas and thyroid: Bridging the gap 181
Red blood cell deformability in multiple myeloma 180
The difference of free light chains as a predictor of kidney damage in patients with Multiple Myeloma 166
Thrombotic risk in paroxysmal nocturnal hemoglobinuria-like (PNH-like) phenotype 157
Risk stratification for invasive fungal infections in patients with hematological malignancies: SEIFEM recommendations 148
Paroxysmal nocturnal haemoglobinuria: When delay in diagnosis and long therapy occurs 145
An assessment of the hemorheological profile in patients with subclinical carotid atherosclerosis divided in relation to the number of cardiovascular risk factors and different degrees of insulin resistance 144
Network meta-analysis of randomized trials in multiple myeloma. Efficacy and safety in frontline therapy for patients not eligible for transplant 141
Paroxysmal nocturnal hemoglobinuria-like phenotype and thrombotic risk in several clinical disorders 138
High Output Heart Failure in Multiple Myeloma: Pathogenetic Considerations 131
Calculated Whole Blood Viscosity and Albumin/Fibrinogen Ratio in Patients with a New Diagnosis of Multiple Myeloma: Relationships with Some Prognostic Predictors 121
Bone damage and health-related quality of life in Hodgkin lymphoma survivors: closing the gaps 113
Erythrocyte deformability profile evaluated by laser diffractometry in patients with multiple myeloma: Re-examination of our cases 105
Leukocyte subtypes, gelatinases, and their tissue inhibitors in a group of subjects with asymptomatic carotid atherosclerosis 100
Changes in RDW according to prognostic predictors in newly diagnosed multiple myeloma 100
Red Cell Distribution Width and Elongation Index in a Cohort of Patients With Juvenile Acute Myocardial Infarction 99
Uric acid and uric acid/creatinine ratio and their correlations with the hemorheological determinants in subjects with subclinical carotid atherosclerosis 97
Calculated haemorheological profile and laboratory parameters in new diagnosed multiple myeloma patients: retrospective analysis according to survival 96
Calculated whole blood viscosity in non-diabetic subjects with asymptomatic carotid atherosclerosis: How insulin resistance may affect blood viscosity 92
Polymorphonuclear phenotypical expression of CD18, at baseline and after in vitro activation, in several clinical disorders: Revision of our case series 90
Neutrophil/HDL-C, Lymphocyte/HDL-C and Monocyte/HDL-C in subjects with asymptomatic carotid atherosclerosis 77
Reflections on the unexpected laboratory finding of hemorheological alterations observed in some haematological disorders 76
Thrombotic Risk and Calculated Whole Blood Viscosity in a Cohort of Patients With New Diagnosis of Multiple Myeloma 58
Red Blood Cell Distribution Width, Erythrocyte Indices, and Elongation Index at Baseline in a Group of Trained Subjects 54
Prognostic potential of albumin to fibrinogen ratio in multiple myeloma patients 42
Totale 6.663
Categoria #
all - tutte 24.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.594


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022237 0 0 0 17 8 14 23 20 35 50 19 51
2022/2023613 52 98 9 76 70 85 53 49 61 17 37 6
2023/2024406 16 56 37 58 28 55 34 28 5 7 27 55
2024/2025731 24 41 27 70 33 28 92 58 62 73 88 135
2025/20262.366 184 114 150 165 239 370 354 246 166 175 103 100
2026/2027766 133 263 281 89 0 0 0 0 0 0 0 0
Totale 6.663